ing. M.R. (Marinella) Visser

No picture available
Telephone:
E-mail:
m.r.visser rug.nl

Research

Publications
  1. NICOTINAMIDE COMPOSITIONS AND THE THERAPEUTIC USE THEREOF

    Meijerink, H. J. C., Changoer, L., Blom, W., Visser, M. R., Frijlink, H. W. & Eissens, A. C., 17-Jan-2013, IPC No. A61P 25/ 14 A I, Patent No. WO2013009186, Priority date 14-Jul-2011, Priority No. EP20110173963

    Research output: Patent

  2. Surface-active derivative of inulin (Inutec® SP1) is a superior carrier for solid dispersions with a high drug load

    Srinarong, P., Hämäläinen, S., Visser, M. R., Hinrichs, W. L. J., Ketolainen, J. & Frijlink, H. W., Jun-2011, In : Journal of Pharmaceutical Sciences. 100, 6, p. 2333-2342 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles

    Saluja, V., Visser, M. R., ter Veer, W., van Roosmalen, M. L., Leenhouts, K., Hinrichs, W. L. J., Huckriede, A. & Frijlink, H. W., 23-Nov-2010, In : Vaccine. 28, 50, p. 7963-7969 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particles

    Saluja, V., Visser, M. R., van Roosmalen, M. L., Leenhouts, K., Huckriede, A., Hinrichs, W. L. J. & Frijlink, H. W., Nov-2010, In : European Journal of Pharmaceutics and Biopharmaceutics. 76, 3, p. 470-474 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (13) »

ID: 195428